This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allured, V, Collier, R. J., Carroll, S. F, and McKay, D. B., 1986, Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Ångstomresolution, Proc. Natl. Acad. Sci. U.S.A. 83:1320–1324.
Baldwin, R.L., 1991, Molten globules:specific or nonspecific folding intermediates?, Chemtracts-Biochem. Mol. Biol. 2:379–389.
Christensen, H., and Pain, R. H., 1991, Molten globule intermediates and protein folding, Ear. Biophys. J. 19:221–229.
Dobson, C. M., 1992, Unfolded proteins, compact states and molten globules, Curr. Opin. Struct. Biol. 2:6–12.
Draper, R. K., and Simon, M. I., 1980, The entry of diphtheria toxin into the mammalian cell cytoplasm: evidence for lysosomal involvement, J. Cell Biol. 87:849–854.
Edwards, G. M., DeFeo-Jones, D., Tai, J. Y., Vuocolo, G. A., Patrick, D. R., Heimbrook, D. C., and Oliff, A., 1989, Epidermal growth factor receptor binding is affected by structural determinants in the toxin domain of transforming growth factor-alpha-Pseudomonas exotoxin fusion protein, Mol. Cell Biol. 9:2860–2867.
Farahbakhsh, Z. T., and Wismeski, B. J., 1989, The acid-triggered entry pathway of Pseudomonas exotoxin A, Biochemistry 28:580–585.
George, H. A., Powell, A. L., Dahlgren, M. E., Herber, W. K., Maigetter, B., Burgess, W., Stirdivant, S. M., and Greasham, R. L., 1992, Physiological effects of TGF-α-PF40 expression in recombinant Escherichia coli JM 109, Biotech. Bioeng. 40:437–445.
Goldberg, M. R., Heimbrook, D. C., Russo, P., Sarosdy, M. F., Greenberg, R. E., Giantonio, B. J., Linehan, W. M., Walther, M., Fisher, H. A. G., Messing, E., Crawford, E. D., Oliff, A. I., and Pastan, I. H., 1995, Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer, Clin. Cancer Res. 1:57–61.
Goto, Y., and Fink, A. L., 1989, Conformational states of β-laclamase: molten-globule states at acidic and alkaline pHwith high salt. Biochemistry 28:945–952.
Gress, J. O., Marquis-Omer, D., Middaugh, C. R., and Sanyal, G., 1994, Evidence for an equilibrium intermediate in thefolding-unfolding pathway of atrans forming growth factor-α-Pseudomonas exotoxin hybrid protein, Biochemistry 33:2620–2627.
Haigler, H.T., Maxfield, F.R., Willingham, M.C., and Pastan, I., 1980, Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells, J. Biol. Chem. 255:1239–1241.
Heimbrook, D. C., Stirdivant, S. M., Ahern, J. D., Balishin, N. L., Patrick, D. R., Edwards, G. M., DeFeo-Jones, D., FitzGerald, D. J., Pastan, I., and Oliff, A., 1990, Transforming growth factor-α-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts, Proc. Nat/. Acad. Sci. U.S.A. 87:4697–4701.
Jiang, J. X., and London, E., 1990, Involvement of denaturation-like changes in Pseudomonas exotoxin A hydrophobicity and membrane penetration determined by characterization of pH and thermal transitions, J. Biol. Chem. 265:8636–8641.
Kline, T. P., Brown, F.K., Brown, S. C., Jeffs, P. W., Kopple, K. D., and Mueller, L., 1990, Solutions tructures of human trans forming growth factor 1H NMR data, Biochemistry 29:7805–7813.
Kounnas, M. Z., Morris, R. E., Thompson, M. R., FitzGerald, D. J., Strickland, D. K., and Saelinger, C. B., 1992, The α2-macrolobulin receptor/lowdensitylipoprotein receptor-related proteinbinds and internalizes Pseudomonas exotoxin A, J. Biol. Chem. 267:12420–12423.
Kuwajima, K., 1989, The molten globule state as a clue for understanding the folding and cooperativity of globular-protein structure, Proteins: Struct. Funct. Genet. 6:87–103.
Linemeyer, D. L., Kelly, L. J., Menke, J. G., Gimenez-Gallego, G., DiSalvo, J., and Thomas, K. A., 1987, Expression in Escherichia coli of a chemically synthesized gene for biologically active bovine acidic fibroblast growth factor, Bio/Technology 5:960–965.
Mach, H., Ryan, J. A., Burke, C. J., Volkin, D. B., and Middaugh, C. R., 1993, Partially structured self-associating states of acidic fibroblast growth factor. Biochemistry 32:7703–7711.
Manavalan, P., and Johnson, W. C., Jr., 1987, Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra, Anal. Biochem. 167:76–85.
Massagué, J., 1990, Transforming growth factor-α, J. Biol. Chem. 265:21393–21396.
Pastan, I., Chaudhary, V., and FitzGerald, D. J., 1992, Recombinant toxins as novel therapeutic agents, Ann. Rev. Biochem. 61:331–354.
Pastan, I., and FitzGerald, D., 1989, Pseudomonas exotoxin: chimeric toxins, J. Biol. Chem. 264:15157–15160.
Prestrelski, S. J., Arakawa. T, Wu, C.-S. C., O’Neal, K. D., Westcott, K. R., and Narhi, L. O., 1992, Solution structure and dynamics of epidermal growth factor and transforming growth factor α, J. Biol. Chem. 267:319–322.
Sandvig, K., and Moskaug, J. Ø 1987, Pseudomonas toxin binds Triton X-114 at low pH, Biochem. J. 245: 899–901.
Sanyal, G., Marquis-Omer, D., Gress, J. O., and Middaugh, C. R., 1993, A transforming growth factor-α-Pseudomonas exotoxin hybrid protein undergoes pH-dependent conformational changes conducive to membrane interaction, Biochemistry 32:3488–3497.
Susi, H., and Byler, D.M., 1986, Resolution-enhanced Fourier transform infrared spectroscopy of enzymes, Meth. Knzymol. 130:290–311.
Von Hoff, D. D., Marshall, M. H., Heimbrook, D. C., Stirdivant, S. M., Ahern, J. D., Herbert, W. K., Maigetter, R.Z., and Oliff, A., 1992, Activity of arecom binant transforming growth factor-α-Pseudomonas exotoxin hybrid protein against primary human tumor colony-forming units, Invest. New Drugs 10:17–22.
Yamazaki, S., Sardana, M. K., and Lee, A. L., 1995, A rapid copper metal interaction high performance liquid chromatography assay tor monitoring disulfide isomerization of TP40 (a recombinant fusion protein TGFα-PE40δcys), submitted.
Zalman, L. S., and Wisnieski, B. J., 1985, Characterization of the insertion of Pseudomonas exotoxin A into membranes, Infect. Immun. 50:630–635.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Sanyal, G., Marquis-Omer, D., Russell Middaugh, C. (2002). Biophysical Characterization and Formulation of TP40: A Chimeric Protein that Requires a pH-Dependent Conformational Change for Its Biological Activity. In: Pearlman, R., Wang, Y.J. (eds) Formulation, Characterization, and Stability of Protein Drugs: Case Histories. Pharmaceutical Biotechnology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/0-306-47452-2_10
Download citation
DOI: https://doi.org/10.1007/0-306-47452-2_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45332-8
Online ISBN: 978-0-306-47452-1
eBook Packages: Springer Book Archive